allyl-(6-diazo-5-oxo)-norleucyl-(6-diazo-5-oxo)-norleucine has been researched along with Trypanosomiasis, African in 1 studies
*Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusawa, T; Ichimura, M; Ishiyama, A; Masuma, R; Namatame, M; Nishihara, A; Omura, S; Otoguro, K; Shiomi, K; Takahashi, Y; Yamada, H | 1 |
1 other study(ies) available for allyl-(6-diazo-5-oxo)-norleucyl-(6-diazo-5-oxo)-norleucine and Trypanosomiasis, African
| Article | Year |
|---|---|
In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Topics: Animals; Cell Line; Dipeptides; Drug Discovery; Female; Humans; In Vitro Techniques; Methylglucosides; Mice; Mice, Inbred ICR; Molecular Structure; Parasitic Sensitivity Tests; Soil Microbiology; Terpenes; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2008 |